- Citations, last 5 years
- 356.5k
- Works, last 5 years
- 25.4k
- h-index
- 1,797
- Scientists listed
- 655
- Grants since 2016
- 3 144
Grants received
2009–2023 · research · R01
Transcriptional control of gut epithelial homeostasis and regeneration
Ramesh A Shivdasani · Dana-Farber Cancer Institute · funded by National Institutes of Health
2009–2020 · training · T32
Research Training in Pediatric Oncology
Scott A Armstrong · Dana-Farber Cancer Institute · funded by National Institutes of Health
2009–2020 · program · P01
Mechanisms, Prevention and Treatment of Chronic Graft-vs.-Host Disease
Corey S Cutler · Dana-Farber Cancer Institute · funded by National Institutes of Health
2009–2020 · research · R01
BRCA1 Function in Post-Damage Nuclear Foci
David Morse Livingston · Dana-Farber Cancer Institute · funded by National Institutes of Health
2009–2024 · research · R01
Transcriptional control of gut epithelial homeostasis and regeneration
Ramesh A Shivdasani · Dana-Farber Cancer Institute · funded by National Institutes of Health
2009–2025 · training · T32
Research Training in Pediatric Oncology
Scott A Armstrong · Dana-Farber Cancer Institute · funded by National Institutes of Health
2009–2020 · program · P01
Mechanisms, Prevention and Treatment of Chronic Graft-vs.-Host Disease
Corey S Cutler · Dana-Farber Cancer Institute · funded by National Institutes of Health
2009–2023 · research · R01
Targeting ALK through Degradation and Allosteric Inhibitors
Nathanael Schiander Gray · Dana-Farber Cancer Institute · funded by National Institutes of Health
2009–2021 · program · P01
Mechanisms, Prevention and Treatment of Chronic Graft-vs.-Host Disease
Corey S Cutler · Dana-Farber Cancer Institute · funded by National Institutes of Health
2009–2020 · research · R01
BRCA1 Function in Post-Damage Nuclear Foci
David Morse Livingston · Dana-Farber Cancer Institute · funded by National Institutes of Health
2009–2021 · research · R01
Targeting ALK through Degradation and Allosteric Inhibitors
Nathanael Schiander Gray · Dana-Farber Cancer Institute · funded by National Institutes of Health
2009–2025 · training · T32
Research Training in Pediatric Oncology
Scott A Armstrong · Dana-Farber Cancer Institute · funded by National Institutes of Health
2009–2020 · program · P01
Mechanisms, Prevention and Treatment of Chronic Graft-vs.-Host Disease
Corey S Cutler · Dana-Farber Cancer Institute · funded by National Institutes of Health
2009–2025 · training · T32
Research Training in Pediatric Oncology
Scott A Armstrong · Dana-Farber Cancer Institute · funded by National Institutes of Health
2009–2025 · training · T32
Research Training in Pediatric Oncology
Scott A Armstrong · Dana-Farber Cancer Institute · funded by National Institutes of Health
2009–2023 · research · R01
Transcriptional control of gut epithelial homeostasis and regeneration
Ramesh A Shivdasani · Dana-Farber Cancer Institute · funded by National Institutes of Health
2009–2025 · training · T32
Research Training in Pediatric Oncology
Scott A Armstrong · Dana-Farber Cancer Institute · funded by National Institutes of Health
2009–2023 · research · R01
Transcriptional control of gut epithelial homeostasis and regeneration
Ramesh A Shivdasani · Dana-Farber Cancer Institute · funded by National Institutes of Health
2009–2020 · program · P01
Mechanisms, Prevention and Treatment of Chronic Graft-vs.-Host Disease
Corey S Cutler · Dana-Farber Cancer Institute · funded by National Institutes of Health
2009–2023 · research · R01
Targeting ALK through Degradation and Allosteric Inhibitors
Nathanael Schiander Gray · Dana-Farber Cancer Institute · funded by National Institutes of Health
2009–2020 · research · R01
BRCA1 Function in Post-Damage Nuclear Foci
David Morse Livingston · Dana-Farber Cancer Institute · funded by National Institutes of Health
2009–2021 · program · P01
Core B: Cell Banking and Immune Assessment Core
Jerome Ritz · Dana-Farber Cancer Institute · funded by National Institutes of Health
2009–2021 · program · P01
Project 2: Preclinical Drug Approaches to Chronic Graft-vs.-Host-Disease Prevention and Treatment
Bruce R Blazar · Dana-Farber Cancer Institute · funded by National Institutes of Health
2009–2021 · program · P01
Project 3: Humoral Targets and B Cell Biology in Chronic Graft-vs.-Host Disease
Jerome Ritz · Dana-Farber Cancer Institute · funded by National Institutes of Health
2009–2021 · program · P01
Project 1: Targeting B Cells in Chronic Graft-vs.Host Disease Prevention and Treatment
Corey S Cutler · Dana-Farber Cancer Institute · funded by National Institutes of Health
2009–2021 · program · P01
Core D: Data Management Core
Vincent Trien-Vinh Ho · Dana-Farber Cancer Institute · funded by National Institutes of Health
2009–2021 · program · P01
Core C: Biostatistics Core
Haesook T Kim · Dana-Farber Cancer Institute · funded by National Institutes of Health
2009–2021 · program · P01
Core A: Administrative Core
Corey S Cutler · Dana-Farber Cancer Institute · funded by National Institutes of Health
2009–2021 · program · P01
Core E: Experimental Therapeutics Core
Jun Qi · Dana-Farber Cancer Institute · funded by National Institutes of Health
2008–2022 · research · R01
Thermogenic chromatin remodeling control and fat tissue communication
Pere Puigserver · Dana-Farber Cancer Institute · funded by National Institutes of Health
2008–2023 · research · R01
Thermogenic chromatin remodeling control and fat tissue communication
Pere Puigserver · Dana-Farber Cancer Institute · funded by National Institutes of Health
2008–2021 · research · R01
Dual role of BAD in insulin secretion and beta cell survival
Nika N Danial · Dana-Farber Cancer Institute · funded by National Institutes of Health
2008–2022 · research · R01
Thermogenic chromatin remodeling control and fat tissue communication
Pere Puigserver · Dana-Farber Cancer Institute · funded by National Institutes of Health
2008–2023 · research · R01
Development and validation of clinical prediction models for the use and interpretation of multigene hereditary cancer risk assessment
Sapna Syngal · Dana-Farber Cancer Institute · funded by National Institutes of Health
2008–2027 · research · R01
Metabolic crosstalks in regulation of beta-cell stress response and adaptation
Nika N Danial · Dana-Farber Cancer Institute · funded by National Institutes of Health
2008–2021 · research · R01
Dual role of BAD in insulin secretion and beta cell survival
Nika N Danial · Dana-Farber Cancer Institute · funded by National Institutes of Health
2008–2025 · research · R01
Development and validation of clinical prediction models for the use and interpretation of multigene hereditary cancer risk assessment
Sapna Syngal · Dana-Farber Cancer Institute · funded by National Institutes of Health
2008–2027 · research · R01
Metabolic crosstalks in regulation of beta-cell stress response and adaptation
Nika N Danial · Dana-Farber Cancer Institute · funded by National Institutes of Health
2008–2023 · research · R01
Development and validation of clinical prediction models for the use and interpretation of multigene hereditary cancer risk assessment
Sapna Syngal · Dana-Farber Cancer Institute · funded by National Institutes of Health
2008–2021 · research · R01
Dual role of BAD in insulin secretion and beta cell survival
Nika N Danial · Dana-Farber Cancer Institute · funded by National Institutes of Health
